Malignant mesothelioma: prognostic variables in a registry of 180 patients, the Dana-Farber Cancer Institute and Brigham and Women's Hospital experience over two decades, 1965-1985.

No abstract is available for this paper.

• Publication year

  1988

• Venue

  Journal of Clinical Oncology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1200/JCO.1988.6.1.147PMID 3335886
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Phase II trial of high-dose cisplatin in patients with malignant mesothelioma.

  1985cited by this paper
• Early peritoneal mesothelioma: a treatable malignancy.

  1985cited by this paper
• Randomized trial of doxorubicin versus cyclophosphamide in diffuse malignant pleural mesothelioma.

  1985cited by this paper
• Surgical treatment of pleural mesothelioma.

  1982cited by this paper
• Diffuse malignant mesothelioma. Prospective evaluation of 69 patients.

  1982cited by this paper
• Diffuse, mixed malignant pleural mesothelioma.

  1981cited by this paper
• Multimodality therapy for malignant mesothelioma based on a study of natural history.

  1980cited by this paper
• The value of adriamycin in the treatment of diffuse malignant pleural mesothelioma

  1978cited by this paper
• Surgical management of malignant mesothelioma.

  1978cited by this paper
• Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura. Experience with 29 patients.

  1976cited by this paper

• Prognostic factors and the prognostic role of inflammation indices in malignant pleural mesothelioma

  2023cites this paper
• Does Platelet Count Affect Survival Outcomes in Patients with Malignant Pleural Mesothelioma?

  2022cites this paper
• Quantitative Assessment of Asbestos Fibers in Normal and Pathological Peritoneal Tissue—A Scoping Review

  2022cites this paper
• Differential diagnosis and treatment of primary peritoneal cancer and mesothelioma

  2021cites this paper
• A Clinico-Pathologic Approach to the Differential Diagnosis of Pericardial Tumors

  2021cites this paper
• Malignant peritoneal mesothelioma: prognostic significance of clinical and pathologic parameters and validation of a nuclear-grading system in a multi-institutional series of 225 cases

  2020cites this paper
• Gender-based Disparities in Receipt of Care and Survival in Malignant Pleural Mesothelioma.

  2020cites this paper
• Peritoneal Mesothelioma: Diagnosis and Management

  2019cites this paper
• Diagnostic value of biopsy sampling in predicting histology in patients with diffuse malignant pleural mesothelioma

  2019cites this paper
• Characteristics and long‐term outcomes of advanced pleural mesothelioma in Latin America (MeSO‐CLICaP)

  2019cites this paper
• Current Concepts in the Diagnosis and Management of Patients With Malignant Peritoneal Mesothelioma

  2019cites this paper
• Treatment and Outcomes of Primary Pericardial Mesothelioma: A Contemporary Review of 103 Published Cases

  2019cites this paper
• Ten-year experience with peritoneal mesothelioma.

  2019cites this paper
• Cytoreductive Surgery and Intraperitoneal Chemotherapy for Treatment of Malignant Peritoneal Mesothelioma

  2019cites this paper
• Clinical and Pathological Features Are Still the Best Determinants ofPrognosis in Mesothelioma

  2019cites this paper
• Up to Date Approaches to Treatment of Patients with Pseudomyxoma Peritonei and Peritoneal Mesothelioma

  2019cites this paper
• Peritoneal Metastases from Malignant Mesothelioma.

  2018cites this paper
• Malignant Pleural Mesothelioma presenting with Cardiac Tamponade- A Rare Case report and Review of the literature

  2018cites this paper
• A Retrospective Analysis of Epidemiology Prognostic Factor and Response of Treatment of Malignant Pleural Mesothelioma

  2018cites this paper
• Malignant Peritoneal Mesothelioma with Production of G-CSF : Case Report and Review of the Literature

  2018cites this paper
• Clinicopathologic and genetic characteristics of young patients with pleural diffuse malignant mesothelioma

  2018cites this paper
• Natural History and Staging of Malignant Mesothelloma

  2017cites this paper
• Recent advances of pyrrolopyridines derivatives: a patent and literature review

  2017influential citation
• Mesothelioma survivorship: challenges in delivering quality care

  2017cites this paper
• Peritoneal mesothelioma in a young woman: Case report of radiopathologic findings and review of the literature

  2017cites this paper
• Reproducibility for histologic parameters in peritoneal mesothelioma.

  2017cites this paper
• Epidemiology of mesothelioma of the pericardium and tunica vaginalis testis.

  2017cites this paper
• Diagnosis and management of patients with malignant peritoneal mesothelioma.

  2016cites this paper
• Patterns in the incidence, mortality and survival of malignant pleural and peritoneal mesothelioma, New South Wales, 1972–2009

  2016cites this paper
• Peritoneal mesothelioma unmasked by an acute appendicitis

  2016cites this paper
• Are neutrophil/lymphocyte ratio and platelet/lymphocyte ratio reliable parameters as prognostic indicators in malignant mesothelioma?

  2016cites this paper
• [Peritoneal mesothelioma unmasked by an acute appendicitis].

  2016cites this paper
• Pathologie tumorale du mésentère et du péritoine

  2015cites this paper
• Scuola di Dottorato in Scienze Fisiopatologiche e neuropsicobiologiche e assistenziali del ciclo della vita - Ciclo XXVIII

  2015cites this paper
• HMGB-1 Release and the CD8+ T Cell Response Elicited by Radiation Treatment in Malignant Pleural Mesothelioma

  2015cites this paper
• Treating peritoneal mesothelioma with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. A case series and review of the literature

  2015cites this paper
• The Immunogenic Effect of Local Radiation Therapy in a Murine Model of Mesothelioma

  2015cites this paper
• Malignant Mesothelioma: Asbestos Exposure

  2014cites this paper
• Treatment of diffuse malignant peritoneal mesothelioma (DMPM) by cytoreductive surgery and HIPEC.

  2014cites this paper
• Does Surgery Improve Survival of Patients with Malignant Pleural Mesothelioma?: A Multicenter Retrospective Analysis of 1365 Consecutive Patients

  2014cites this paper
• Photodynamic Therapy for Thoracic Oncology

  2014cites this paper
• Factors associated with survival in a large series of patients with malignant pleural mesothelioma in New South Wales

  2014cites this paper
• Prognostic Factors Affecting Survival in Malignant Pleural Mesothelioma: Analysis of 125 Subjects

  2014cites this paper
• Characterization and drug sensitivity profiling of primary malignant mesothelioma cells from pleural effusions

  2014cites this paper
• Diffuse malignant epithelioid mesothelioma in a background of benign multicystic peritoneal mesothelioma: a case report and review of the literature

  2014cites this paper
• Malignant peritoneal mesothelioma in a child: chemotherapy with gemcitabine and platinum was effective for the disease unresponsive to other treatments.

  2014cites this paper
• Characterization of malignant pleural mesothelioma : possibilities for an individualized therapeutic arsenal

  2014cites this paper
• Diagnostic delay in malignant pleural mesothelioma due to physicians fixation on history with non-exposure to asbestos

  2013cites this paper
• Validation of prognostic factors in malignant pleural mesothelioma: a retrospective analysis of data from patients seeking compensation from the New South Wales Dust Diseases Board.

  2013cites this paper
• Novel 1H-pyrrolo[2,3-b]pyridine derivative nortopsentin analogues: synthesis and antitumor activity in peritoneal mesothelioma experimental models.

  2013cites this paper
• highlights several prognostic biomarkers for malignant mesothelioma.

  2013cites this paper
• Oestrogen receptors are prognostic factors in malignant peritoneal mesothelioma

  2013cites this paper
• Malignant peritoneal mesothelioma: Two cases and literature review

  2013cites this paper
• Proteome Screening of Pleural Effusions Identifies Galectin 1 as a Diagnostic Biomarker and Highlights Several Prognostic Biomarkers for Malignant Mesothelioma

  2013cites this paper
• Ki 67-BCL 2 index in prognosis of malignant peritoneal mesothelioma

  2013cites this paper
• Ki67-BCL2 index in prognosis of malignant peritoneal mesothelioma.

  2013cites this paper
• Guidelines for the diagnosis and treatment of malignant pleural mesothelioma.

  2013cites this paper
• Adjuvant Bidirectional Chemotherapy with Intraperitoneal Pemetrexed Combined with Intravenous Cisplatin for Diffuse Malignant Peritoneal Mesothelioma

  2012influential citation
• Abdominal Advanced Oncologic Surgery

  2012cites this paper
• Current concepts in the evaluation and treatment of patients with diffuse malignant peritoneal mesothelioma.

  2012cites this paper
• High Wilms’ tumour gene (WT1) expression and low mitotic count are independent predictors of survival in diffuse peritoneal mesothelioma

  2012cites this paper
• Clinical and pathological features are still the best determinants of prognosis in mesothelioma.

  2012cites this paper
• Peritoneal mesothelioma: current status and future directions.

  2012cites this paper
• Multicentric study on malignant pleural mesothelioma in Turkey: clinicopathologic and survival characteristics of 282 patients

  2012cites this paper
• Peritoneal Cystic Mesothelioma: Are Surgery and HIPEC Optimal First-Line Treatments?

  2012cites this paper
• Malignant primary peritoneal mesothelioma: report of two cases and review of literature.

  2012cites this paper
• Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma.

  2012cites this paper
• Malignant pleural mesothelioma in Singapore.

  2011cites this paper
• Factors that Impact Susceptibility to Fiber-Induced Health Effects

  2011cites this paper
• Phase II Study of Gemcitabine Plus Docetaxel as Second-Line Treatment in Malignant Pleural Mesothelioma: A Single Institution Study

  2011cites this paper
• Survival and prognostic factors in malignant pleural mesothelioma: a retrospective study of 314 patients in the west part of Japan.

  2011cites this paper
• Asbestos exposure and survival in malignant mesothelioma: a description of 122 consecutive cases at an occupational clinic.

  2011cites this paper
• Advances in diffuse malignant peritoneal mesothelioma

  2011cites this paper
• Overexpression of CD26/DPPIV in mesothelioma tissue and mesothelioma cell lines.

  2011cites this paper
• Improving survival results after surgical management of malignant pleural mesothelioma: an Australian institution experience.

  2011cites this paper
• Metastatic peritoneal mesothelioma in the setting of recurrent ascites: A case report

  2010cites this paper
• Cytoreductive Surgery with Intraperitoneal Hyperthermic Chemotherapy for Malignant Peritoneal Mesothelioma: Mitomycin Versus Cisplatin

  2010cites this paper
• Management of malignant pleural mesothelioma

  2010cites this paper
• Analysis of the Effect of Radiotherapy on Malignant Pleural Mesothelioma when Given on Adjuvant or Palliative Basis

  2010cites this paper
• Modern Soft Tissue Pathology: MALIGNANT MESOTHELIOMA AND OTHER MESOTHELIAL PROLIFERATIONS

  2010cites this paper
• Malignant Pleural Mesothelioma: A Population-Based Study of Survival

  2010cites this paper
• Characteristics of malignant pleural mesothelioma in women.

  2010influential citation
• Proposed adjustments to pathologic staging of epithelial malignant pleural mesothelioma based on analysis of 354 cases

  2010cites this paper
• Living with mesothelioma

  2010cites this paper
• The efficacy of the frontline platinum-based combination chemotherapy in malignant peritoneal mesothelioma.

  2010cites this paper
• Prognostic Factors for 100 Patients With Malignant Pleural Mesothelioma

  2010cites this paper
• Two-stage operative cytoreduction and intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma: Operative morbidity and mortality in phase I and II trials.

  2010cites this paper
• Therapeutic surgery for nonepithelioid malignant pleural mesothelioma: is it really worthwhile?

  2010cites this paper
• Epidemiology of mesothelioma in Egypt. A ten-year (1998-2007) multicentre study

  2010cites this paper
• Malignant abdominal mesothelioma: Defining the role of surgery

  2009cites this paper
• Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience.

  2009cites this paper
• Malignant peritoneal mesothelioma.

  2009cites this paper
• Recent advances in mesothelioma staging.

  2009cites this paper
• Phase II Study of Belinostat (PXD101), a Histone Deacetylase Inhibitor, for Second Line Therapy of Advanced Malignant Pleural Mesothelioma

  2009cites this paper
• [Malignant primary peritoneal tumors].

  2009cites this paper
• CT appearances of pleural tumours.

  2009cites this paper
• Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy for peritoneal surface malignancy: non-colorectal indications.

  2009cites this paper
• Tumeurs malignes primitives du péritoine

  2009cites this paper
• [Peritoneal mesothelioma: treatment with cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy].

  2008cites this paper
• Combined Resection, Intraperitoneal Chemotherapy, and Whole Abdominal Radiation for the Treatment of Malignant Peritoneal Mesothelioma

  2008cites this paper